ECG
MRK icon

Edge Capital Group’s Merck MRK Stock Holding History

Edge Capital Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$18.6M Sell
20,073
-159,265
-89% -$16.4M 0.83% 32
2024
Q3 		$20.4M Buy
179,338
+16,520
+10% +$1.96M 0.9% 31
2024
Q2 		$20.2M Buy
162,818
+4,764
+3% +$614K 0.98% 27
2024
Q1 		$20.9M Buy
158,054
+26,330
+20% +$3.25M 1.04% 24
2023
Q4 		$14.4M Buy
131,724
+10,365
+9% +$1.08M 0.8% 31
2023
Q3 		$12.5M Sell
121,359
-20,339
-14% -$2.19M 0.81% 28
2023
Q2 		$16.4M Buy
141,698
+339
+0.2% +$38.5K 0.94% 23
2023
Q1 		$15M Buy
141,359
+22,388
+19% +$2.42M 0.93% 26
2022
Q4 		$13.2M Buy
118,971
+28,458
+31% +$2.91M 0.92% 23
2022
Q3 		$7.79M Buy
90,513
+86,648
+2,242% +$7.74M 0.64% 34
2022
Q2 		$651K Sell
3,865
-81,722
-95% -$7.24M 0.06% 175
2022
Q1 		$7.02M Sell
85,587
-1,776
-2% -$140K 0.48% 47
2021
Q4 		$6.7M Sell
87,363
-1,124
-1% -$89.5K 0.47% 51
2021
Q3 		$6.65M Buy
88,487
+80,812
+1,053% +$6.15M 0.53% 47
2021
Q2 		$597K Sell
7,675
-2,885
-27% -$215K 0.05% 172
2021
Q1 		$777K Sell
10,560
-2,388
-18% -$176K 0.07% 148
2020
Q4 		$1.01M Buy
12,948
+1,948
+18% +$149K 0.09% 131
2020
Q3 		$871K Buy
11,000
+1,226
+13% +$96K 0.09% 121
2020
Q2 		$721K Sell
9,774
-47
-0.5% -$3.54K 0.08% 128
2020
Q1 		$721K Sell
9,821
-167
-2% -$13.1K 0.09% 126
2019
Q4 		$867K Sell
9,988
-5
-0.1% -$411 0.08% 135
2019
Q3 		$803K Sell
9,993
-675
-6% -$54.1K 0.08% 137
2019
Q2 		$854K Buy
10,668
+648
+6% +$49.6K 0.08% 138
2019
Q1 		$795K Buy
10,020
+122
+1% +$9.13K 0.08% 139
2018
Q4 		$722K Buy
+9,898
New +$699K 0.08% 132

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Edge Capital Group's MRK Position: Q4 2024 in Review

Edge Capital Group reduced its Merck (MRK) stake by 89% in Q4 2024, selling an estimated $16.4M and leaving 20,073 shares worth $18.6M. The position accounts for 0.83% of the portfolio, ranked #32.

Edge Capital Group first reported a position in MRK in Q4 2018 and has held it in 25 quarters since. The position peaked at $20.9M in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Edge Capital Group held 20,073 shares of Merck worth $18.6M as of Q4 2024.
  • Edge Capital Group sold 159,265 Merck shares in Q4 2024, an estimated $16.4M.
  • Merck made up 0.83% of Edge Capital Group's portfolio in Q4 2024, its #32 holding.
  • Edge Capital Group first reported a position in Merck in Q4 2018 and has held it in 25 quarters since.
  • Edge Capital Group's Merck position peaked at $20.9M in Q1 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Edge Capital Group's 13F filing for Q4 2024, filed 4 Feb 2025.